½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

  • »¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

    021-54845833/15800441009

    Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

    µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹PRMT5¶à¿Ë¡¿¹Ìå

    ²úÆ·ÖÐÐÄ

    ×îвúÆ·

    • Íÿ¹PRMT5¶à¿Ë¡¿¹Ìå

      ¹æ¸ñ£º
      ¼Û¸ñ£º£¤
      • Æ·ÅÆ : ͨεÉúÎï
      • Ŀ¼ºÅ : TW21978
      • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
      • »õÆÚ : ÏÖ»õ
      • ¹æ¸ñ £º100ul/200ul/25ul
    • ÉÌÆ·ÏêÇé
    • ²Î¿¼ÎÄÏ×
    • ˵Ã÷ÊéÏÂÔØ
    • ÉÌÆ·ÆÀÂÛ0
    • Ïà¹Ø²úÆ·


    ÖÐÎÄÃû³Æ£º  Íÿ¹PRMT5¶à¿Ë¡¿¹Ìå


    Ó¢ÎÄÃû³Æ£º  Anti-PRMT5 rabbit polyclonal antibody


    ±ð      Ãû£º  JBP1, SKB1, IBP72, SKB1Hs, HRMT1L5


    Ïà¹ØÀà±ð£º  Ò»¿¹


    ´¢      ´æ£º  Àä¶³£¨-20¡æ£©


    ËÞ     Ö÷£º  Rabbit


    ¿¹     Ô­£º  PRMT5


    ·´Ó¦ÖÖÊô£º  Human, Mouse, Rat


    ±ê  ¼Ç Î   Unconjugate


    ¿Ë¡ÀàÐÍ£º  rabbit polyclonal


    ¼¼Êõ¹æ¸ñ

    Background:

    Protein arginine methyltransferase 5 has been shown to interact with WD repeat-containing protein 77, CLNS1A, Janus kinase 2, SNRPD3 and SUPT5H.Arginine methyltransferase that can both catalyze the formation of omega-N monomethylarginine (MMA) and symmetrical dimethylarginine (sDMA), with a preference for the formation of MMA. Specifically mediates the symmetrical dimethylation of arginine residues in the small nuclear ribonucleoproteins Sm D1 (SNRPD1) and Sm D3 (SNRPD3); such methylation being required for the assembly and biogenesis of snRNP core particles. Methylates SUPT5H. Mono- and dimethylates arginine residues of myelin basic protein (MBP) in vitro. Plays a role in the assembly of snRNP core particles. May play a role in cytokine-activated transduction pathways. Negatively regulates cyclin E1 promoter activity and cellular proliferation.

    Applications:

    ELISA, WB, IHC

    Name of antibody:

    PRMT5

    Immunogen:

    Synthetic peptide of human PRMT5

    Full name:

    protein arginine methyltransferase 5

    Synonyms£º

    JBP1, SKB1, IBP72, SKB1Hs, HRMT1L5

    SwissProt:

    O14744

    ELISA Recommended dilution:

    1000-2000

    IHC positive control:

    Human breast cancer and Human tonsil

    IHC Recommend dilution:

    15-50

    WB Predicted band size:

    71 kDa

    WB Positive control:

    K562, hela and 293T cells

    WB Recommended dilution:

    200-1000







  • ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
  • ¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿